一个新的竞争性内源性RNA与阿尔茨海默病中失调的神经炎症相关
Dinesh Devadoss1, Juliet Akkaoui1, Natalia Orso1
1Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Cells
|March 14, 2026
概括
研究人员发现了一种新的长非编码RNA,LIMASI,它在阿尔茨海默氏症 (AD) 大脑中升高,与神经炎症有关. 利马西可以作为ceRNA (竞争性内源RNA) 调节炎症途径,为AD提供潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默病 (AD) 的特点是神经炎症,这是进展的关键驱动力.
- 长非编码RNAs (lncRNAs) 与AD有关,但它们的具体作用尚不清楚.
- 识别AD病变的新型分子参与者对于开发新疗法至关重要.
研究的目的:
- 识别和描述涉及AD相关神经炎症的新型lncRNAs.
- 阐明在AD病变发生过程中发现的lncRNA的机制性作用.
- 探索针对这种lncRNA在AD治疗干预的潜力.
主要方法:
- 使用死后AD脑组织和3xTg-AD小鼠模型识别了一种新的lncRNA,LIMASI.
- 定量PCR (qPCR) 和RNA光 in situ杂交 (FISH) 来评估LIMASI表达.
- 在体外研究中,在APP过度表达细胞中使用聚I:C) 挑战来模拟神经炎症.
- 计算建模用于预测miRNA-lncRNA相互作用.
主要成果:
- 在AD大脑和小鼠模型中,LIMASI表达显著上调,与AD病理标志物相关联.
- 在炎症期间,LIMASI表达在星细胞和微质细胞中是可诱导的.
- 利马西与促炎性微RNAs (miR-155-5p,miR-150-5p) 相互作用,支持一个ceRNA机制.
- 升调LIMASI与增加的神经炎症信号传递有关.
结论:
- LIMASI是一种新型的lncRNA,与阿尔茨海默氏症中神经炎症密切相关.
- 利马西作为竞争的内源RNA (ceRNA) 起作用,调节炎症基因网络.
- 向LIMASI可能提供一种新的治疗策略,以减少神经炎症并减缓AD的进展.
相关概念视频
02:30siRNA - Small Interfering RNAs
18.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.9K
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
01:37Neural Regulation
44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
02:23RNA Editing
10.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
10.1K
02:15Experimental RNAi
8.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
01:23RNA Interference
28.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.4K